Detalhe da pesquisa
1.
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
N Engl J Med
; 384(25): 2394-2405, 2021 06 24.
Artigo
Inglês
| MEDLINE | ID: mdl-34081848
2.
Unveiling the potential of breast MRI: a game changer for BI-RADS 4A microcalcifications.
Breast Cancer Res Treat
; 206(2): 425-435, 2024 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-38664289
3.
Adjuvant medial versus entire supraclavicular lymph node irradiation in high-risk early breast cancer (SUCLANODE): a protocol for a multicenter, randomized, open-label, phase 3 trial.
BMC Cancer
; 24(1): 49, 2024 Jan 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38195438
4.
Pamiparib in patients with locally advanced or metastatic HER2-negative breast cancer with germline BRCA mutations: a phase II study.
Breast Cancer Res Treat
; 197(3): 489-501, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36459284
5.
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
N Engl J Med
; 380(7): 617-628, 2019 02 14.
Artigo
Inglês
| MEDLINE | ID: mdl-30516102
6.
Integration of radiogenomic features for early prediction of pathological complete response in patients with triple-negative breast cancer and identification of potential therapeutic targets.
J Transl Med
; 20(1): 256, 2022 06 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35672824
7.
Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer.
Nucleic Acids Res
; 48(7): 3638-3656, 2020 04 17.
Artigo
Inglês
| MEDLINE | ID: mdl-32112098
8.
A Retrospective Cohort Study Comparing Traditional Breast Conservation With Oncoplastic Surgery in Breast Cancer Patients After Neoadjuvant Chemotherapy.
Ann Plast Surg
; 88(2): 144-151, 2022 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34387578
9.
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China.
Chin J Cancer Res
; 34(6): 592-600, 2022 Dec 30.
Artigo
Inglês
| MEDLINE | ID: mdl-36714346
10.
Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study.
Breast Cancer Res Treat
; 187(3): 759-768, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-33860389
11.
Impact of clinical-pathological factors on locoregional recurrence in mastectomy patients with T1-2N1 breast cancer: who can omit adjuvant radiotherapy?
Breast Cancer Res Treat
; 190(2): 277-286, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34490502
12.
Randomized and dose-escalation trials of recombinant human serum albumin /granulocyte colony-stimulating factor in patients with breast cancer receiving anthracycline-containing chemotherapy.
BMC Cancer
; 21(1): 341, 2021 Mar 31.
Artigo
Inglês
| MEDLINE | ID: mdl-33789616
13.
Pertuzumab and trastuzumab as adjuvant treatment for HER2-positive early breast cancer: outcomes in Chinese patients in the APHINITY study.
Jpn J Clin Oncol
; 51(3): 345-353, 2021 Mar 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33619550
14.
A nomogram for predicting axillary pathologic complete response in hormone receptor-positive breast cancer with cytologically proven axillary lymph node metastases.
Cancer
; 126 Suppl 16: 3819-3829, 2020 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32710664
15.
Current Status and Factors Influencing Surgical Options for Breast Cancer in China: A Nationwide Cross-Sectional Survey of 110 Hospitals.
Oncologist
; 25(10): e1473-e1480, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32333626
16.
Neoadjuvant therapy and sentinel lymph node biopsy in HER2-positive breast cancer patients: results from the PEONY trial.
Breast Cancer Res Treat
; 180(2): 423-428, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-32034581
17.
Pertuzumab, trastuzumab, and docetaxel for Chinese patients with previously untreated HER2-positive locally recurrent or metastatic breast cancer (PUFFIN): a phase III, randomized, double-blind, placebo-controlled study.
Breast Cancer Res Treat
; 182(3): 689-697, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32564260
18.
Mirtazapine, a dopamine receptor inhibitor, as a secondary prophylactic for delayed nausea and vomiting following highly emetogenic chemotherapy: an open label, randomized, multicenter phase III trial.
Invest New Drugs
; 38(2): 507-514, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32036491
19.
Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases.
Breast Cancer Res Treat
; 178(2): 251-261, 2019 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-31388936
20.
The Impact of Radiotherapy on Reoperation Rates in Patients Undergoing Mastectomy and Breast Reconstruction.
Ann Surg Oncol
; 26(4): 961-968, 2019 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-30675702